BioCentury's websites will be down for upgrades starting at 11 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

5:58 PM
Oct 24, 2008
 |  BC Extra  |  Politics & Policy

FDA panel discusses AD imaging agents

On Thursday, FDA's Peripheral and Central Nervous System Drugs Advisory Committee agreed that a radionucleotide approved to detect cerebral beta amyloid would be clinically useful to help rule out a diagnosis of Alzheimer's disease. However, the panel felt too many questions remain about...

Read the full 196 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >